Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Cancer Immunology, Immunotherapy : CII|November 5, 2024
Dendritic cell maturation is induced by p53-armed oncolytic adenovirus via tumor-derived exosomes enhancing systemic antitumor immunityTomoko Ohtani, Shinji Kuroda, Nobuhiko Kanaya, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|May 21, 2025
The prognostic effect of recurrent laryngeal nerve palsy after esophagectomy in locally advanced esophageal squamous cell carcinoma: A multi-center retrospective studyKoichi Ogawa, Takeshi Toyozumi, Kazuhiro Noma, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 23, 2021
Local oncolytic adenovirotherapy produces an abscopal effect via tumor-derived extracellular vesiclesYoshihiko Kakiuchi, Shinji Kuroda, Nobuhiko Kanaya, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|January 29, 2020
Immune Modulation by Telomerase-Specific Oncolytic Adenovirus Synergistically Enhances Antitumor Efficacy with Anti-PD1 AntibodyNobuhiko Kanaya, Shinji Kuroda, Yoshihiko Kakiuchi, et al.
Internal Medicine (Tokyo, Japan)|October 18, 2019
Poorly Differentiated Hepatocellular Carcinoma in a Low-risk Patient with an Otherwise Normal LiverNobuhiko Ogasawara, Satoshi Saitoh, Hideyuki Denpou, et al.
Scientific Reports|November 4, 2025
Serum extracellular vesicles containing adenoviral E1A-DNA as a predictive biomarker for liquid biopsy in oncolytic adenovirus therapyChiaki Yagi, Shinji Kuroda, Yoshihiko Kakiuchi, et al.
Cancer Immunology, Immunotherapy : CII|December 18, 2025
Gut microbial metabolite butyrate boosts p53-expressing telomerase-specific oncolytic adenovirus efficacy by enhancing infectivity and activating MHC-I/cGAS-STINGMasaki Sakamoto, Shinji Kuroda, Tetsuya Katayama, et al.
British Journal of Cancer|February 5, 2024
Long-term activation of anti-tumor immunity in pancreatic cancer by a p53-expressing telomerase-specific oncolytic adenovirusMasashi Hashimoto, Shinji Kuroda, Nobuhiko Kanaya, et al.
RSC Medicinal Chemistry|October 28, 2024
Correction: Anti-schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysisKennosuke Itoh, Hiroki Nakahara, Atsushi Takashino, et al.
RSC Medicinal Chemistry|October 14, 2024
Anti-Schistosomal activity and ADMET properties of 1,2,5-oxadiazinane-containing compound synthesized by visible-light photoredox catalysisKennosuke Itoh, Hiroki Nakahara, Atsushi Takashino, et al.
Pageof 10